MiR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytes

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 4, 2014, Pages 334-343

  Bhatia, Himanshi ^a,b   Verma, Gaurav ^a,b   Datta, Malabika ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

ER stress; Fatty acid synthase; Fatty liver; Lipid; MicroRNA

Indexed keywords

4 PHENYLBUTYRIC ACID; BIOLOGICAL MARKER; FATTY ACID SYNTHASE; LIPID; MALONYL COENZYME A; MICRORNA 107; MICRORNA 107 INHIBITOR; PROTEIN INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIPID STORAGE; LIVER CELL; MEDIATOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REPORTER GENE;

ER STRESS; FATTY ACID SYNTHASE; FATTY LIVER; LIPID; MICRORNA;

3' UNTRANSLATED REGIONS; BINDING SITES; ENDOPLASMIC RETICULUM STRESS; FATTY ACID SYNTHASES; FATTY ACIDS; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIVER; MALONYL COENZYME A; MICRORNAS;

EID: 84897014065     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.02.009     Document Type: Article

References (51)

1. Wang H., Kouri G., Wollheim C.B. ER stress and SREBP-1 activation are implicated in β-cell lipotoxicity. J. Cell Sci. 2005, 118:3905-3915.
2. Postic C., Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 2008, 118:829-838.
3. Jornayvaz F.R., Shulman G.I. Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab. 2012, 15:574-584.
4. Anderson N., Borlak J. Molecular mechanisms and therapeutic targets in steatosis and steatoheptitis. Pharmacol. Rev. 2008, 60:311-357.
5. Niederau C. NAFLD and NASH. Hepatology - A Clinical Textbook 2013, 450-458. Flying Publisher, Germany. 4th edition. S. Mauss, T. Berg, J. Rockstroh, C. Sarrazin, H. Wedemeyer (Eds.).
6. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S. Prevalence of and risk factors for non-alcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
7. Min H.K., Kapoor A., Fuchs M., Mirshahi F., Zhou H., Maher J., Kellum J., Warnick R., Contos M.J., Sanyal A.J. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with severity of non-alcoholic fatty liver disease. Cell Metab. 2012, 15:665-674.
8. Farese R.V., Zechner R., Newgard C.B., Walther T.C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 2012, 15:570-573.
9. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004, 116:281-297.
10. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
11. Pandey A.K., Agarwal P., Kaur K., Datta M. MicroRNAs in diabetes: tiny players in big disease. Cell. Physiol. Biochem. 2009, 23:221-232.
12. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA related disease. Transl. Res. 2011, 157:253-264.
13. Rottiers V., Näär A.M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 2012, 13:239-251.
14. Rotllan N., Fernandez-Hernando C. MicroRNA regulation of cholesterol metabolism. Cholesterol 2012, 2012:1-8.
15. Ji J., Zhang J., Huang G., Qian J., Wang X., Mei S. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate activation. FEBS Lett. 2009, 583:759-766.
16. Pandey A.K., Verma G., Vig S., Srivastava S., Srivastava A.K., Datta M. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol. Cell. Endocrinol. 2010, 332:125-133.
17. Jin X., Ye Y.F., Chen S.H., Yu C.H., Liu J., Li Y.M. MicroRNA expression pattern in different stages of non-alcoholic fatty liver disease. Dig. Liver Dis. 2009, 41:289-297.
18. Cheung O., Puri P., Eicken C., Contos M.J., Mirshahi F., Maher J.W., Kellum J.M., Min H., Luketic V.A., Sanyal A.J. Non-alcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 2008, 48:1810-1820.
19. Li S., Chen X., Zhang H., Liang X., Xiang Y., Yu C., Zen K., Li Y., Zhang C.Y. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J. Lipid Res. 2009, 50:1756-1765.
20. Trajkovski M., Hausser J., Soutschek J., Bhat B., Akin A., Zavolan M., Heim M.H., Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011, 474:649-654.
21. Kaur K., Pandey A.K., Srivastava S., Srivastava A.K., Datta M. Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver. Mol. Biosyst. 2011, 7:3234-3244.
22. Koteish A., Diehl A.M. Animal models of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16:679-690.
23. Kornfeld J.W., Baitzel C., Konner A.C., Nicholls H.T., Vogt M.C., Herrmanns K., Scheja L., Haumaitre C., Wolf A.M., Knippschild U., Seibler J., Cereghini S., Heeren J., Stoffel M., Bruning J.C. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 2013, 494:111-115.
24. Foley N.H., O'Neill L.A. miR-107: a toll-like receptor-regulated microRNA dysregulated in obesity and type 2 diabetes. J. Leukoc. Biol. 2012, 92:521-527.
25. Wilfred B.R., Wang W.-X., Nelson P.T. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 2007, 91:209-217.
26. Nagalla S., Shaw C., Kong X., Kondkar A.A., Edelstein L.C., Ma L., Chen J., McKnight G.S., López J.A., Yang L., Jin Y., Bray M.S., Leal S.M., Dong J.-F., Bray P.F. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011, 117:5189-5197.
27. Peña F.A., Kanasaki K., Kanasaki M., Tangirala N., Maeda G., Kalluri R. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J. Biol. Chem. 2011, 286:20778-20787.
28. Yao J., Hennessey T., Flynt A., Lai E., Beal M.F., Lin M.T. MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 2010, 12:1-8.
29. Park I.J., Kim M.J., Park O.J., Choe W., Kang I., Kim S.S., Ha J. Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells. Apoptosis 2012, 17:248-257.
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
31. Vickers K.C., Shoucri B.M., Levin M.G., Wu H., Pearson D.S., Osei-Hwedieh D., Collins F.S., Remaley A.T., Sethupathy P. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 2013, 57:533-542.
32. Tanabe K., Liu Y., Hasan S.D., Martinez S.C., Cras-Meneur C., Welling C.M., Bernal-Mizrachi E., Tanizawa Y., Rhodes C.J., Zmuda E., Hai T., Abumrad N.A., Alan Permutt M. Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation. PLoS One 2011, 6:e18146.
33. Park J.H., Ahn J., Kim S., Kwon D.Y., Ha T.Y. Murine hepatic miRNAs expression and regulation of gene expression in diet-induced obese mice. Mol. Cells 2011, 31:33-38.
34. Jayakumar A., Tai M.H., Huang W.Y., al-Feel W., Hsu M., Abu-Elheiga L., Chirala S.S., Wakil S.J. Human fatty acid synthase: properties and molecular cloning. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8695-8699.
35. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., Turk J., Semenkovich C.F. "New" hepatic fat activates PPAR to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005, 1:309-322.
36. Little J.L., Wheeler F.B., Fels D.R., Koumenis C., Kridel S.J. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res. 2007, 67:1262-1269.
37. Fu S., Yang L., Li P., Hofmann O., Dicker L., Hide W., Lin X., Watkins S.M., Ivanov A., Hotamisligil G.S. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011, 473:528-531.
38. Sriburi R., Jackowski S., Mori K., Brewer J.W. XBP-1: a link between the unfolded protein response, lipid biosynthesis and biogenesis of the endoplasmic reticulum. J. Cell Biol. 2004, 167:35-41.
39. Sha H., He Y., Chen H., Wang C., Zenno A., Shi H., Yang X., Zhang X., Qi L. The IRE1α-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab. 2009, 9:556-564.
40. Hanson P.J., Zhang H.M., Hemida M.G., Ye X., Qiu Y., Yang D. Viral Replication Strategies: Manipulation of ER Stress Response Pathways and Promotion of IRES-Dependent Translation. Viral Replication 2013, 103-126. InTech Publisher. I.G. Rosas-Acosta (Ed.).
41. Lu P.D., Harding H.P., Ron D. Translation reinitiation at alternate open reading frames regulates gene expression in an integrated stress response. J. Cell Biol. 2004, 167:27-33.
42. Damiano F., Rochira A., Tocci R., Alemanno S., Gnoni A., Siculella L. HnRNP A1 mediates the action of IRES-dependent SREBP-1a mRNA translation in response to endoplasmic reticulum stress. J. Biochem. 2013, 449:543-553.
43. Özcan U., Yilmaz E., Özcan L., Furuhashi M., Vaillancourt E., Smith R.O., Görg̈n C.Z., Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313:1137-1140.
44. Kim A.J., Shi Y., Austin R.C., Werstuck G.H. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J. Cell Sci. 2004, 118:89-99.
45. Mosbah I.B., Alfany-Fernandez I., Martel C., Zaouali M.A., Bintanel-Morcillo M., Rimola A., Rodes J., Brenner C., RoselloD́-Catafau J., Peralta C. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis. 2010, 1:1-12.
46. Lee J.N., Ye J. Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 2004, 279:45257-45265.
47. Chen Y., Brandizzi F. IRE1: ER stress sensor and cell fate executor. Trends Cell Biol. 2013, 23:547-555.
48. Lee A.H., Scapa E.F., Cohen D.E., Glimcher L.H. Regulation of hepatic lipogenesis by the transcription factor XBP-1. Science 2008, 320:1492-1496.
49. Rutkowski D.T., Wu J., Back S.-H., Callaghan M.U., Ferris S.P., Iqbal J., Clark R., Miao H., Hassler J.R., Fornek J., Katze M.G., Hussain M.M., Song B., Swathirajan J., Wang J., Yau G.D.-Y., Kaufman R.J. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev. Cell 2008, 15:829-840.
50. Gubern A., Barcelo-Torns M., Casas J., Barneda D., Masgrau R., Picatoste F., Balsinde J., Balboa M.A., Claro E. Lipid droplet biogenesis induced by stress involves triacylglycerol synthesis that depends on group VIA phospholipase A2. J. Biol. Chem. 2009, 284:5697-5708.
51. Yamamoto K., Takahara K., Oyadomari S., Okada T., Sato T., Harada A., Mori K. Induction of liver steatosis and lipid droplet formation in ATF6α-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol. Biol. Cell 2010, 21:2975-2986.